We have seen how the genetic diversity within a tumor can be used to estimate the tumor’s age (see Figure 13.14).This analysis depends on mutation rate per cell division being constant.
a. If a cancerous tumor has evolved a high mutation rate, how will this bias the results?
b. Do the genetic markers we use to estimate a tumor’s age need to be selectively neutral? Why or why not?
We need at least 10 more requests to produce the solution.
0 / 10 have requested this problem solution
The more requests, the faster the answer.